Navigation Links
Weight Loss and Effects on Diabetes with Qnexa Treatment Results Presented at the World Diabetes Congress
Date:12/7/2011

are needed to address the parallel epidemics of diabetes and obesity, and that QNEXA could be a potential non-surgical approach to both treat obesity and improve glycemic control in obese diabetic patients."

Full slide presentation is available at www.vivus.com.

About QNEXAQNEXA [kyoo-nek-suh] is an investigational drug candidate being developed to address weight loss, type 2 diabetes and obstructive sleep apnea. QNEXA is a once-a-day, proprietary, oral, controlled-release formulation of low-dose phentermine and topiramate, which is designed to decrease appetite and increase satiety (the sense of feeling full), the two main mechanisms that impact eating behavior. In phase 2 and 3 clinical data to date, patients taking QNEXA have demonstrated statistically significant weight loss, glycemic control, and improvement in cardiovascular risk factors, when used in combination with a diet and lifestyle modification program.

About VIVUS VIVUS is a biopharmaceutical company developing therapies to address obesity, sleep apnea, diabetes and male sexual health.  The company's lead investigational product in clinical development, Qnexa, has completed phase 3 clinical trials for the treatment of obesity and is currently being considered for approval by US and EU regulators.  VIVUS received a Complete Response Letter, or CRL, to the initial Qnexa NDA on October 28, 2010.  We resubmitted the Qnexa NDA in October 2011, with an FDA action date of April 17, 2012.  Qnexa is also in phase 2 clinical development for the treatment of type 2 diabetes and obstructive sleep apnea.  In the area of sexual health, VIVUS has submitted an NDA for avanafil, a PDE5 inhibitor being studied for the treatment of erectile dysfunction, with an FDA action date of April 29, 2012.  For more information about the company, please visit www.vivus.com. 

Cer
'/>"/>

SOURCE VIVUS, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
2. ArtJen Announces Major Clinical Trial of Its Patented Weight Loss Product FBCx
3. DOV 21,947 Demonstrates Significant Body Weight and BMI Reductions in Drug- Compliant Subjects in Phase Ib Clinical Study
4. Surgeons Find That Laparoscopic Banding Procedure Helps Overweight Adolescents Lose Weight and Improve Health
5. Study Results Reveal alli(R) Patient Satisfaction Linked to Weight Loss Achieved; Not Treatment Effects
6. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
7. LAP-BAND(R) System Weight-Loss Surgery Associated With More Than 70 Percent Reduced Risk of Death in People With Severe Obesity
8. Vanderbilt Medical Center Seeks Middle Tennesseans with Type 2 Diabetes Who are Overweight for National Clinical Trial
9. Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)
10. Bone Mineral Content Continues to Increase in Obese Adolescents During Weight Loss
11. Medifast Outperforms American Diabetes Association Diet by Twice the Weight Loss According to Published Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... 17, 2013 Research explores ... outcomes research also   to   be presented ... SHPG ), the global specialty biopharmaceutical company, announces that ... at the American Psychiatric Association (APA) 166th Annual Meeting ... The data being presented represent Shire,s ongoing commitment to ...
(Date:5/17/2013)... /PRNewswire-iReach/ -- The escalation of new biological drugs, ... emphasis on alternate delivery technologies. Alternate delivery technologies ... factors are converging to create both risk ... device partners . These include new classes of ... toward self-administration for chronic diseases, shifting patient demographics ...
(Date:5/17/2013)...  Boehringer Ingelheim will contribute to advancing the ... Thoracic Society International Conference (ATS 2013) in ... 22. Data will highlight research conducted ... chronic obstructive pulmonary disease (COPD) [Spiriva® HandiHaler® (tiotropium ... for asthma, idiopathic pulmonary fibrosis (IPF) and COPD. ...
Breaking Medicine Technology:Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 2Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 3Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 4Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 5Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 6Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 7Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 8Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 9Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting 10Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 2Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 3Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 4Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 5Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 6Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 7Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference 8
(Date:5/18/2013)... 18, 2013 The Communities of Distinction ... places we call home. These are the townships, villages and ... the locations where the people are friendly and neighbors are ... off the highways and shares the best in both the ... with an American sports and film celebrity. It airs in ...
(Date:5/18/2013)... FL (PRWEB) May 18, 2013 TheBeautyPlace.com ... Nioxin. Pattern hair loss is not a result of ... According to Men’s Fitness Magazine, 70% of men suffer ... Professional Strength is renowned for hair transplant surgery, ... fights male pattern baldness known as Bosley Professional Strength. ...
(Date:5/18/2013)... 2013 Although obesity is associated with ... between obesity and esophageal adenocarcinoma, a type of esophageal ... As reported on Cancer.gov, last reviewed in ... as likely as those of normal and healthy weight ... obesity and esophageal cancer is not well understood, it ...
(Date:5/18/2013)... Adolescents, especially young males, who experiment with ... are landing in emergency rooms across America. ... with a new treatment program for those addicted ... from the National Institute on Drug Abuse, synthetic marijuana ... teenagers. In 2012, 11 percent of high school seniors ...
(Date:5/18/2013)... 2013 Rio Salon and Spa, a ... stylish renovation that features tranquil, Eastern Asian influenced furnishings, ... ground up, this Morro Bay day spa ... colors and comfortable spa beds. Additional salon stations and ... epilator machine. The shampoo area has been upgraded ...
Breaking Medicine News(10 mins):Health News:Communities of Distinction TV Presents "A Place to Call Home" Segment 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 2Health News:TheBeautyPlace.com Features the Two New Best-Selling Hairloss Products: Bosley Professional Strength and Nioxin Systems 3Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 2Health News:hCGtreatments / Diet Doc Hcg Diets & Weight Loss Plans Announces New Prescription Hcg Diet Plans Designed to Trim Inches and Thus Reduce the Risk of Esophageal Cancer 3Health News:Spice Addiction Treatment and Synthetic Marijuana Drug Rehab Announced by Recovery Associates 2Health News:Rio Salon and Spa, a Beauty Salon in Morro Bay, Undergoes Makeover 2
... of Alabama at Birmingham (UAB) researchers have found that ... patients infected by human immunodeficiency virus (HIV) is generally ... confirmed TB cases. The study, published in ... this summer, relied on treatment-cost estimates from previous ...
... exposure to lead in the environment is associated with ... studies have looked at lead concentrations in blood, not ... over time. In a new study, researchers at the ... of Michigan School of Public Health found that bone ...
... Raises Costs, Unfairly Targets Labs , , ... Baucus, (D-MT) plan to impose $750 million in taxes on ... -- translates into a disproportionate cut for laboratories, will damage ... costs," according to Alan Mertz, President of the American Clinical ...
... WASHINGTON, Sept. 9 As Obama prepares to address ... challenged the nation,s Catholic bishops to be prepared to shut down ... action to compromising with the intrinsic evils currently contained in various ... http://www.newscom.com/cgi-bin/prnh/20081105/DC44231LOGO ) , , "Obama ...
... , , A Public ... , The National Press Club , 529 14th Street, NW ... Sept. 9 On September 19 a number of organizations are joining in ... more affordable and more responsive to the individual rights and choices of Americans. ...
... CITY, Calif., Sept. 9 Abaxis, Inc. (Nasdaq: ABAX ... today that Clint Severson, chairman and chief executive officer, will present ... Thursday, September 17, 2009 at 10:00 a.m. ET. The conference will ... City. , , About Abaxis ...
Cached Medicine News:Health News:UAB researchers find TB-prevention therapy is cost-effective option 2Health News:Lead in bone associated with increased risk of death from cardiovascular disease in men 2Health News:ACLA Opposes Proposed LabTax 2Health News:A.L.L.: Bishops Must Choose Between Christ-Centered Care and Obamacare 2Health News:Joint Briefing on Proposed Health Care Reform 2Health News:Joint Briefing on Proposed Health Care Reform 3
A "doughy" type of bone cement intended for manual application....
... The Videoscopes provide superior image quality ... to the camera head with a ... ensures more light at the operative ... optimum image clarity and reliability.,The Videoscopes ...
... a wide range of innovative features, including ... Control (U.S. Patent #4,684,227). Stereopsis is maximized ... Heine's unique Diffuser aperture absorbs only 30% ... and simplifying difficult examinations. A newly incorporated ...
... 3-wire patient cable and 4 ... of the unit. 3-step procedure enabling ... 8 or 12 lead ECG through ... position. Records 2.5 seconds per lead ...
Medicine Products: